Red List

TMDXTransMedics Group, Inc.

Healthcare · Medical Devices · mid-cap ($2.1B)
-56.5%
from rolling 252-day high of $156.00 set 2025-12-02 · 177d ago
Current
$67.83
Decline depth
-56.5%
Decline σ
5.6σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$TMDX landed on the list 2026-03-14, down 20.1% from its 52-week high that day — now down -56.5%.

That's 32.0 percentage points deeper than the day it joined. It bottomed 60.2% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

TMDX qualifies for the Red List on decline depth.

Decline depth
-56.5%
From rolling 252-day high of $156.00, 177d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
5.6σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (6.05% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about TMDX.

TMDX qualifies for the Red List on decline depth — down -56.5% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 5.6σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 2D (red).

Earnings on file: 2026-05-05. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $60.10 8.1% of range 52W high $156.00

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

88 Red List
47 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about TMDX

What people ask.

Why is TMDX on Broken Stocks?

TMDX qualifies for the Red List on decline depth. It is down -56.5% from its rolling 252-day high of $156.00, set on 2025-12-02 — 177d ago.

Is TMDX a falling knife?

Not by the strict technical definition. TMDX is down -56.5% from its 52-week high, but that high was set 177d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. TMDX is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is TMDX a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is TMDX trading inside its 52-week range?

At $67.83, TMDX sits 8.1% of the way from its 52-week low ($60.10) to its 52-week high ($156.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has TMDX been declining?

The current 56.5% decline accrued over 177d, which annualizes to roughly -116.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does TMDX compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — TMDX's decline is deeper than the sector median.

Does TMDX's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.